Arax Advisory Partners’s Prelude Therapeutics PRLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-19	Closed	-$40	–	2676
2024 Q3	$40	Hold	19	–	–	﹤0.01%	2593
2024 Q2	$73	Buy	+19	New	+$73	﹤0.01%	2506